We know the non-binding agreement is for HIV with

We know the non-binding agreement is for HIV with upfront and milestone payments. It is not Incell because the relationship is already established with the CTC test. It has to be some pharma that is or wants to be in HIV. All of the other indications have been "packaged" (Nader's words), ready for a partner deal that has not happened yet, so that is not what will be detailed out tomorrow. My guess is that HIV combo will not go cheap and Mono certainly will not. This agreement was not described as a "merger", The partner company must be big enough to put up the cash for HIV, so i doubt it is some private company. If it is a publicly traded company, they will likely be the ones to PR the deal first, then Cytodyn. Tonight or tomorrow morning we might find out. The CC will be to explain from our point of view.